-
August 26, 2019
The Importance of Brain Tumor-Initiating Cells in Glioblastoma
With:A Q&A with Anita Hjelmeland, PhD, Associate Professor of Cell, Developmental and Integrative Biology at the University of Alabama Birmingham School of Medicine; hjelmea@uab.edu Q: The inner workings of malignant gliomas are mysterious to many of us. Why does the prognosis of patients with these tumors remain poor? A: Glioblastoma is a primary brain tumor that is treated with surgery, radiation, and chemotherapy. While… Read more »
-
August 17, 2019
Primary Hepatic Carcinoma Bookmark
George Lundberg, MDCurated by Editor in Chief George Lundberg, MD, who notes:
Primary liver cell cancer is one of the most common causes of cancer deaths throughout the world. Usually arising in cirrhotic livers, its treatment modalities are many and varied. Cures are elusive except for liver transplantation, but many therapy modalities can sustain prolonged survival. This overview from Medscape provides useful information about the disease.
.
-
August 17, 2019
Ovarian Cancer—An Overview Bookmark
George Lundberg, MDCurated by Editor in Chief George Lundberg, MD, who notes:
Ovarian cancer is particularly difficult; since early symptoms are few, it is often well-advanced before diagnosis. It kills more Americans than any other gynecologic malignancy. The cell types of origin vary greatly, as do treatment modalities. This multi-author 2019 review from Medscape includes established and experimental therapies.
-
August 17, 2019
Endometrial Carcinoma—An Overview Bookmark
George Lundberg, MDCurated by Editor in Chief George Lundberg, MD, who notes:
There are two principal forms of uterine cancer: cervical and endometrial. Endometrial carcinoma is the most frequent cancer of the female genitalia in the developed world, with about 3% of U.S. women likely to receive such a diagnosis. This 2018 review from Medscape is comprehensive. -
August 17, 2019
Esophageal Cancer—An Overview Bookmark
George Lundberg, MDCurated by Editor in Chief George Lundberg, MD, who notes:
Esophageal carcinoma is the ninth most frequently diagnosed potentially lethal cancer worldwide, although there is great geographic variation in disease frequency and cell type of origin. This August 2019 treatise from Medscape illustrates all major aspects.
.
-
August 17, 2019
Chronic Myelogenous Leukemia (CML) Bookmark
George Lundberg, MDCurated by Editor in Chief George Lundberg, MD, who notes:
Once uniformly fatal, chronic myelogenous leukemia (CML) is now a serious but manageable chronic disease of adults. This credible review published in 2018 by Medscape provides useful, in-depth information.
.
-
August 17, 2019
Chronic Lymphocytic Leukemia (CLL) Bookmark
George Lundberg, MDCurated by Editor in Chief George Lundberg, MD, who notes:
Approximately 20,000 Americans, mostly elderly, will be diagnosed with chronic lymphocytic leukemia (CLL) each year. There is no cure, but proper medication management can often provide 5 to 10 years of reasonable life. This practical 2019 discourse from Medscape is a reliable source.
.
-
August 17, 2019
Acute Myeloid Leukemia (AML)—An Overview Bookmark
George Lundberg, MDCurated by Editor in Chief George Lundberg, MD, who notes:
Acute myeloid leukemia is a particularly difficult-to-treat form of leukemia. There are standard treatments, but it may be best for a patient to consider a clinical trial early on. This article from Medscape clearly specifies diagnostic and therapeutic options.
.
-
August 17, 2019
Acute Lymphoblastic Leukemia (ALL)—An Overview Bookmark
George Lundberg, MDCurated by Editor in Chief George Lundberg, MD, who notes:
Acute lymphoblastic leukemia (also known as childhood leukemia) is a serious but often treatable form of leukemia. This authoritative presentation from Medscape is recent, trustworthy, and comprehensive.
.
-
August 15, 2019
Prostate Cancer—An Overview Bookmark
George Lundberg, MDCurated by Editor in Chief George Lundberg, MD, who notes:
Prostate cancer is the most common potentially lethal cancer diagnosed among American men. The great majority do not die of their disease. But there are many controversies about best handling. To learn more, read this authoritative, detailed presentation from Medscape, published August 2019.
.